NasdaqGM - Nasdaq Real Time Price USD

CareDx, Inc (CDNA)

13.32 +0.31 (+2.42%)
As of 12:15 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
275,111.00
280,324.00
321,793.00
296,397.00
192,194.00
--
Cost of Revenue
101,967.00
101,999.00
112,212.00
97,389.00
63,117.00
--
Gross Profit
173,144.00
178,325.00
209,581.00
199,008.00
129,077.00
--
Operating Expense
272,900.00
283,068.00
286,812.00
228,734.00
146,792.00
--
Operating Income
-99,756.00
-104,743.00
-77,231.00
-29,726.00
-17,715.00
--
Net Non Operating Interest Income Expense
12,086.00
11,867.00
3,762.00
160.00
271.00
--
Other Income Expense
-95,590.00
-97,267.00
-2,765.00
-2,522.00
-2,306.00
--
Pretax Income
-183,260.00
-190,143.00
-76,234.00
-32,088.00
-19,750.00
--
Tax Provision
-66.00
141.00
379.00
-1,426.00
-1,036.00
--
Net Income Common Stockholders
-183,194.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
--
Diluted NI Available to Com Stockholders
-183,194.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
--
Basic EPS
-3.42
-3.54
-1.44
-0.59
-0.40
--
Diluted EPS
-3.42
-3.54
-1.44
-0.59
-0.40
--
Basic Average Shares
53,276.99
53,764.71
53,321.63
52,241.08
46,481.77
--
Diluted Average Shares
53,276.99
53,764.71
53,321.63
52,241.08
46,481.77
--
Total Operating Income as Reported
-198,376.00
-203,363.00
-77,231.00
-29,726.00
-22,528.00
--
Total Expenses
374,867.00
385,067.00
399,024.00
326,123.00
209,909.00
--
Net Income from Continuing & Discontinued Operation
-183,194.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
--
Normalized Income
-84,612.52
-112,382.10
-76,697.53
-30,763.34
-17,296.74
--
Interest Income
12,086.00
11,867.00
3,762.00
160.00
271.00
--
Net Interest Income
12,086.00
11,867.00
3,762.00
160.00
271.00
--
EBIT
-99,756.00
-104,743.00
-77,231.00
-29,726.00
-17,715.00
--
EBITDA
-79,473.00
-84,919.00
-61,224.00
-17,841.00
-8,171.00
--
Reconciled Cost of Revenue
101,967.00
101,999.00
112,212.00
97,389.00
63,117.00
--
Reconciled Depreciation
20,283.00
19,824.00
16,007.00
11,885.00
9,544.00
--
Net Income from Continuing Operation Net Minority Interest
-183,194.00
-190,284.00
-76,613.00
-30,662.00
-18,714.00
--
Total Unusual Items Excluding Goodwill
-98,617.00
-98,610.00
107.00
106.00
-1,495.00
--
Total Unusual Items
-98,617.00
-98,610.00
107.00
106.00
-1,495.00
--
Normalized EBITDA
19,144.00
13,691.00
-61,331.00
-17,947.00
-6,676.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-35.52
-20,708.10
22.47
4.66
-77.74
--
12/31/2019 - 7/17/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PSNL Personalis, Inc.
1.3798
+6.16%
 
VCYT Veracyte, Inc.
20.94
+0.92%
 
TWST Twist Bioscience Corporation
43.91
+4.80%
 
NTRA Natera, Inc.
106.52
-0.01%
 
BDSX Biodesix, Inc.
1.3800
-3.50%
 
GH Guardant Health, Inc.
27.40
+1.11%
 
EXAS Exact Sciences Corporation
44.28
-2.57%
 
NEO NeoGenomics, Inc.
13.66
-0.36%
 
CSTL Castle Biosciences, Inc.
23.14
-0.52%
 
LAB Standard BioTools Inc.
2.4650
-0.60%